However, booster vaccination led to an increase in the percentage of IgG1+ and decrease in the percentage of IgM+ spike-specific memory B cells in COVID-19-naïve PAD patients to levels comparable to that seen in healthy donors post primary vaccination (Figures 3B, C; S4B, C). The gene discussed is CD40LG; the disease is peripheral arterial disease.